Late-occurring toxicity induced by an immune checkpoint blockade in adjuvant treatment of a stage III melanoma patient

被引：24
|
作者：
Mandala, Mario [1 ]
Merelli, Barbara [1 ]
Indriolo, Amedeo [2 ]
Tondini, Carlo [1 ]
机构：
[1] Papa Giovanni XXIII Hosp, Dept Hematol & Oncol, Med Oncol Unit, Bergamo, Italy
[2] Papa Giovanni XXIII Hosp, Gastroenterol Unit, Bergamo, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 95卷
关键词：
ANTI-PD-1; THERAPY; IPILIMUMAB;
D O I：
10.1016/j.ejca.2018.02.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：130 / 132
页数：3
相关论文
共 50 条
  • [1] Neoadjuvant Versus Adjuvant Immune Checkpoint Blockade in the Treatment of Clinical Stage III Melanoma
    Yun Song
    Richard J. Straker
    Xiaowei Xu
    David E. Elder
    Phyllis A. Gimotty
    Alexander C. Huang
    Tara C. Mitchell
    Ravi K. Amaravadi
    Lynn M. Schuchter
    Giorgos C. Karakousis
    Annals of Surgical Oncology, 2020, 27 : 2915 - 2926
  • [2] Neoadjuvant Versus Adjuvant Immune Checkpoint Blockade in the Treatment of Clinical Stage III Melanoma
    Song, Yun
    Straker, Richard J., III
    Xu, Xiaowei
    Elder, David E.
    Gimotty, Phyllis A.
    Huang, Alexander C.
    Mitchell, Tara C.
    Amaravadi, Ravi K.
    Schuchter, Lynn M.
    Karakousis, Giorgos C.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (08) : 2915 - 2926
  • [3] Response to Checkpoint Blockade and Survival in Patients with Stage III Melanoma
    Theriot, J.
    Bello, D.
    Lobaugh, S.
    Bartlett, E. K.
    Betof, A.
    Shoushtari, A.
    Postow, M.
    Callahan, M.
    Brady, M. S.
    Wong, R.
    Chapman, P.
    Wolchok, J.
    Panageas, K.
    Coit, D. G.
    Ariyan, C. E.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S155 - S156
  • [4] Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade
    Johannet, Paul
    Liu, Wenke
    Fenyo, David
    Wind-Rotolo, Megan
    Krogsgaard, Michelle
    Mehnert, Janice M.
    Weber, Jeffrey S.
    Zhong, Judy
    Osman, Iman
    CLINICAL CANCER RESEARCH, 2022, 28 (18) : 4121 - 4130
  • [5] Another Victory for Immune Checkpoint Blockade in Melanoma: Adjuvant Ipilimumab Over Interferon
    Betof Warner, Allison
    Postow, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06) : 529 - +
  • [6] Adjuvant ipilimumab for stage III melanoma: the patient voice
    Brundage, Michael
    Hanna, Timothy
    LANCET ONCOLOGY, 2017, 18 (03): : 282 - 284
  • [7] T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma
    Alexander X. Lozano
    Aadel A. Chaudhuri
    Aishwarya Nene
    Antonietta Bacchiocchi
    Noah Earland
    Matthew D. Vesely
    Abul Usmani
    Brandon E. Turner
    Chloé B. Steen
    Bogdan A. Luca
    Ti Badri
    Gunsagar S. Gulati
    Milad R. Vahid
    Farnaz Khameneh
    Peter K. Harris
    David Y. Chen
    Kavita Dhodapkar
    Mario Sznol
    Ruth Halaban
    Aaron M. Newman
    Nature Medicine, 2022, 28 : 353 - 362
  • [8] T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma
    Lozano, Alexander X.
    Chaudhuri, Aadel A.
    Nene, Aishwarya
    Bacchiocchi, Antonietta
    Earland, Noah
    Vesely, Matthew D.
    Usmani, Abul
    Turner, Brandon E.
    Steen, Chloe B.
    Luca, Bogdan A.
    Badri, Ti
    Gulati, Gunsagar S.
    Vahid, Milad R.
    Khameneh, Farnaz
    Harris, Peter K.
    Chen, David Y.
    Dhodapkar, Kavita
    Sznol, Mario
    Halaban, Ruth
    Newman, Aaron M.
    NATURE MEDICINE, 2022, 28 (02) : 353 - +
  • [9] Educational Review: Clinical Application of Immune Checkpoint Blockade for the Treatment of Melanoma
    David Su
    Harriet Kluger
    Kelly Olino
    Annals of Surgical Oncology, 2024, 31 : 1865 - 1879
  • [10] Educational Review: Clinical Application of Immune Checkpoint Blockade for the Treatment of Melanoma
    Su, David
    Kluger, Harriet
    Olino, Kelly
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (03) : 1546 - 1552
12345